EZRICARE EYE DROPS LAWSUITS

EzriCare & Delsam Pharma Artificial Tears Bacterial Infections

If you or someone you love suffered harm after using EzriCare or Delsam Pharma eye drops, you may have grounds to pursue legal action and a financial recovery of your damages.

According to the CDC, EzriCare Artificial Tears and Delsam Pharma Artificial Tears have been linked to antibiotic-resistant bacterial infections and cases of hospitalization, vision loss, eye removal, and death. As of May 2023, regulators have identified over 80 infections in 18 states connected to the eye drops.

Now, Levy Konigsberg is investigating claims from victims and families who suffered harm and losses caused by EzriCare or Delsam Pharma Artificial Tears. If you have a potential case, we want to help.

Levy Konigsberg is an award-winning trial practice known nationally for litigating high-stakes claims involving unsafe pharmaceuticals, serious injuries, and wrongful death. Our firm has recovered more than $3 billion in compensation for clients and has the experience and resources to help plaintiffs fight back against powerful pharmaceutical companies.

EzriCare & Delsam Eye Drops Linked to Fatal Bacterial Infection

EzriCare Artificial Tears and Delsam Pharma Artificial Tears are over-the-counter eye drops manufactured by Global Pharma Healthcare. They were sold nationwide in multidose bottles in brick-and-mortar and online stores such as Walmart and Amazon.

While the eye drops are intended to be sterile, consumer complaints and investigations conducted by federal regulators have revealed that they were contaminated with a rare, extensively drug-resistant strain of Pseudomonas aeruginosa bacteria – specifically, Verona Integron-mediated Metallo-β-lactamase (VIM)- and Guiana-Extended Spectrum-β-Lactamase (GES).

Given the rising number of injuries, hospitalizations, and deaths, and at the request of the FDA, Global Pharma Healthcare issued a voluntary recall for three affected products in February 2023. This includes:

• EzriCare Artificial Tears
• Delsam Pharma Artificial Tears
• Delsam Pharma Artificial Eye Ointment

EzriCare & Delsam Eye Drops Linked to Fatal Bacterial Infection

The P. aeruginosa linked to EzriCare and Delsam Pharma eye drops is a rare strain of bacteria that has not been previously identified in the U.S. According to the CDC, it is notoriously difficult to treat, capable of rapidly self-replicating, and has been found to be extensively resistant to a range of antibiotics commonly used to treat severe infections.

Infections caused by EzriCare and Delsam Pharma Artificial Tears have been linked to:

• Keratitis (inflammation of the cornea)
• Endophthalmitis (infection of eye tissue or fluids)
• Respiratory or urinary tract infection
• Sepsis
• Hospitalization
• Vision loss / blindness
• Surgical eye removal
• Death

As of May 15, 2023, P aeruginosa infections linked to EzriCare and Delsam Pharma eye drops have been associated with a total of 81 infections in 18 states. Of these infections, 14 resulted in vision loss, 4 with surgical removal of the eyeball (enucleation), and 4 deaths.

EzriCare & Delsam Eye Drops Linked to Fatal Bacterial Infection

A growing number of victims across the country are now filing lawsuits against Global Pharma and other entities responsible for manufacturing, supplying, and marketing EzriCare and Delsam Pharma eye drops.

At the core of their lawsuits, victims allege that Global Pharma failed to meet its legal obligations to ensure that its products were safe to use as intended. To support these claims, many point to the FDA’s findings of Global Pharma’s current good manufacturing practice (CGMP) violations, including:

• Lack of appropriate microbial testing
• Formulation issues (i.e. failing to use an adequate preservative)
• Lack of proper controls concerning tamper-evidence packaging

Additional investigations into Global Pharma and its liability remain ongoing. At Levy Konigsberg, we’re closely tracking updates from federal regulators and working with professional experts of our own to explore potential claims that can be brought against at-fault defendants.

How Much is an EzriCare Eye Drops Lawsuit Worth?

Generally, victims in personal injury lawsuits are entitled to a financial recovery of their damages. This may include:

• Pain and suffering
• Lost income and future wages
• Past and future medical expenses
• Disability and lost quality of life
• Lost emotional and financial support
• Other economic and non-economic damages

Litigation over EzriCare and Delsam Pharma eye drops is still in its early stages, and investigations are ongoing. This, coupled with the fact that every case is different, can make it difficult for plaintiffs to assess the potential value of their claims. As such, the best way to gauge the types of damages you may be able to recover is to have your matter reviewed personally by an attorney.

Civil lawsuits are subject to a statute of limitations, which functions as a type of legal deadline. If the statute of limitations in your case expires, you will not be able to file a lawsuit or recover compensation for your damages.

For this reason, it is strongly recommended that anyone with a potential claim reach out to our firm as soon as possible. Timely action can ensure that you are able to file a claim within the appropriate timeframe, and that the necessary work can be done to build the strongest claim possible.

Levy Konigsberg is a U.S. News “Best Law Firms” rated trial practice with a legacy of litigating some of the nation’s most complex and high-profile cases. Our attorneys have decades of experience representing victims in claims involving defective products and pharmaceutical liability, and are standing by to discuss your potential case and how we can help.